Recent content by peibol16

Response of doctor Strick today by mail (responsible for studies cyoctol) to question about forget of cyoctol. "The rights to it were purchased by the drug company that had minoxidil and they never did anything further, so they bought out the potential competition" More info in spanish forum

RU58841/PSK-3841: Phase II A topical, non-steroidal androgen antagonist, PSK-3841 (formerly HMR-3841 and RU-58841), is being investigated in France by Proskelia for possible therapeutic value in Androgenetic Alopecia and acne [102,104]. The compound was in Phase II clinical trials as of January 2004 [102,105]...

83% of people, not 83% of hair regrowth. The hair regrowth is 11,3% average in this 83% of subjects and 20% of net regeneration. However, 92% stabilization it is an excellent result. Its mean that this company is continuing its studies in 2011 for fda approving. Finasteride and Ru...

0.5% cyoctol 83% of patients increase hair (11,3% of new hairs) 92% stabilization (stop the hairloss) 90 subjects in the study duration 48 weeks Cyoctol inhibited 78-93% of the DHT binding locally, better than finasteride and Ru. Chantal Burnison resumed his studies in 2011. More...